Cargando…

Effects of dihydroartemisinin on the gut microbiome of mice

Dihydroartemisinin (DHA) is a semisynthetic derivative of artemisinin, which has been found to exhibit a broad range of biological activities, excluding antimalarial effects; however its effects on the gut microbiota remain poorly understood. The present study aimed to investigate the effects of DHA...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanyan, Yang, Yanhong, Lei, Yuting, Yang, Lanxiang, Zhang, Xueying, Yuan, Jian, Lei, Zili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339414/
https://www.ncbi.nlm.nih.gov/pubmed/32468008
http://dx.doi.org/10.3892/mmr.2020.11165
_version_ 1783554885248090112
author Liu, Yanyan
Yang, Yanhong
Lei, Yuting
Yang, Lanxiang
Zhang, Xueying
Yuan, Jian
Lei, Zili
author_facet Liu, Yanyan
Yang, Yanhong
Lei, Yuting
Yang, Lanxiang
Zhang, Xueying
Yuan, Jian
Lei, Zili
author_sort Liu, Yanyan
collection PubMed
description Dihydroartemisinin (DHA) is a semisynthetic derivative of artemisinin, which has been found to exhibit a broad range of biological activities, excluding antimalarial effects; however its effects on the gut microbiota remain poorly understood. The present study aimed to investigate the effects of DHA on the gut microbiome in mice and to determine its potential biological and pharmaceutical activities through its alteration of the gut microbiota. Serum glucose, triglyceride (TG), total cholesterol, lipopolysaccharide, high density lipoprotein-cholesterol, low density lipoprotein-cholesterol, alanine aminotransferase and aspartate aminotransferase levels in mice treated with DHA were analyzed using the corresponding detection kits. In addition, hematoxylin and eosin staining was performed to determine the pathological effects of DHA on the liver, kidney and intestinal tissues of mice, and the effects of DHA on the gut microbiome were analyzed using 16S ribosomal (r)DNA gene analysis. The results demonstrated that the TG serum levels of mice treated with DHA were significantly decreased compared with the control group. Furthermore, 16S rDNA gene analysis demonstrated that the bacterial diversity of mice treated with DHA was enriched compared with the control group. The DHA group exhibited increased numbers of Firmicutes and Saccharibacteria, and decreased Deferribacteres and Actinobacteria compared with the control group at the phylum level. Kyoto Encyclopedia of Genes and Genomes signaling pathway enrichment analysis also revealed that the signaling pathways associated with ‘Energy metabolism’ and ‘Nucleotide metabolism’ were upregulated, whereas the signaling pathways associated with ‘Infectious diseases and ‘Neurodegenerative diseases’ were downregulated in the DHA group compared with the control group. In conclusion, the findings of the present study indicated that DHA may significantly decrease the serum TG levels and alter the gut microbiota, which suggested its potential to be used for the treatment of hyperlipidemia, inflammatory and neurodegenerative disorders.
format Online
Article
Text
id pubmed-7339414
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-73394142020-07-09 Effects of dihydroartemisinin on the gut microbiome of mice Liu, Yanyan Yang, Yanhong Lei, Yuting Yang, Lanxiang Zhang, Xueying Yuan, Jian Lei, Zili Mol Med Rep Articles Dihydroartemisinin (DHA) is a semisynthetic derivative of artemisinin, which has been found to exhibit a broad range of biological activities, excluding antimalarial effects; however its effects on the gut microbiota remain poorly understood. The present study aimed to investigate the effects of DHA on the gut microbiome in mice and to determine its potential biological and pharmaceutical activities through its alteration of the gut microbiota. Serum glucose, triglyceride (TG), total cholesterol, lipopolysaccharide, high density lipoprotein-cholesterol, low density lipoprotein-cholesterol, alanine aminotransferase and aspartate aminotransferase levels in mice treated with DHA were analyzed using the corresponding detection kits. In addition, hematoxylin and eosin staining was performed to determine the pathological effects of DHA on the liver, kidney and intestinal tissues of mice, and the effects of DHA on the gut microbiome were analyzed using 16S ribosomal (r)DNA gene analysis. The results demonstrated that the TG serum levels of mice treated with DHA were significantly decreased compared with the control group. Furthermore, 16S rDNA gene analysis demonstrated that the bacterial diversity of mice treated with DHA was enriched compared with the control group. The DHA group exhibited increased numbers of Firmicutes and Saccharibacteria, and decreased Deferribacteres and Actinobacteria compared with the control group at the phylum level. Kyoto Encyclopedia of Genes and Genomes signaling pathway enrichment analysis also revealed that the signaling pathways associated with ‘Energy metabolism’ and ‘Nucleotide metabolism’ were upregulated, whereas the signaling pathways associated with ‘Infectious diseases and ‘Neurodegenerative diseases’ were downregulated in the DHA group compared with the control group. In conclusion, the findings of the present study indicated that DHA may significantly decrease the serum TG levels and alter the gut microbiota, which suggested its potential to be used for the treatment of hyperlipidemia, inflammatory and neurodegenerative disorders. D.A. Spandidos 2020-08 2020-05-20 /pmc/articles/PMC7339414/ /pubmed/32468008 http://dx.doi.org/10.3892/mmr.2020.11165 Text en Copyright: © Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Liu, Yanyan
Yang, Yanhong
Lei, Yuting
Yang, Lanxiang
Zhang, Xueying
Yuan, Jian
Lei, Zili
Effects of dihydroartemisinin on the gut microbiome of mice
title Effects of dihydroartemisinin on the gut microbiome of mice
title_full Effects of dihydroartemisinin on the gut microbiome of mice
title_fullStr Effects of dihydroartemisinin on the gut microbiome of mice
title_full_unstemmed Effects of dihydroartemisinin on the gut microbiome of mice
title_short Effects of dihydroartemisinin on the gut microbiome of mice
title_sort effects of dihydroartemisinin on the gut microbiome of mice
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339414/
https://www.ncbi.nlm.nih.gov/pubmed/32468008
http://dx.doi.org/10.3892/mmr.2020.11165
work_keys_str_mv AT liuyanyan effectsofdihydroartemisininonthegutmicrobiomeofmice
AT yangyanhong effectsofdihydroartemisininonthegutmicrobiomeofmice
AT leiyuting effectsofdihydroartemisininonthegutmicrobiomeofmice
AT yanglanxiang effectsofdihydroartemisininonthegutmicrobiomeofmice
AT zhangxueying effectsofdihydroartemisininonthegutmicrobiomeofmice
AT yuanjian effectsofdihydroartemisininonthegutmicrobiomeofmice
AT leizili effectsofdihydroartemisininonthegutmicrobiomeofmice